Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Type of information:
experimental study
Adequacy of study:
key study
Study period:
19.09.2016 to 26.01.2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
other: Chromosome aberration test in mammalian cells (in vitro cytogenetic study)

Test material

Constituent 1
Chemical structure
Reference substance name:
1,4-bis(7-methyloctyl) cyclohexane-1,4-dicarboxylate
Cas Number:
313644-32-5
Molecular formula:
C26H48O4
IUPAC Name:
1,4-bis(7-methyloctyl) cyclohexane-1,4-dicarboxylate
Test material form:
liquid

Method

Species / strain
Species / strain / cell type:
lymphocytes:
Metabolic activation:
with and without
Metabolic activation system:
S9 mix from Aroclor 1254
Test concentrations with justification for top dose:
125, 250, 500, 1000, 2000 µg/mL medium of DINCD
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: ethanol
Controls
Untreated negative controls:
yes
Remarks:
ethanol (vehicle)
Negative solvent / vehicle controls:
no
True negative controls:
no
Positive controls:
yes
Positive control substance:
mitomycin C
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION
- Exposure duration: 4 and 24 h without S9 mix; 4h with S9 mix
- Fixation time (start of exposure up to fixation or harvest of cells):
Two hours before termination the cell division was arrested by the addition of 0.5 mL of the spindle poison Colcemid® to each culture (10 µg/mL solution). The tubes were capped and left to incubate for a further two hours.
The cells were harvested by low speed centrifugation (80 - 100 x g) and the pellets of cells collected were resuspended in hypotonic potassium chloride solution (0.56%) and fixed in freshly prepared methanol : glacial acetic acid fixative (4:1, v/v).

SPINDLE INHIBITOR (cytogenetic assays):
Colcemid®

STAIN (for cytogenetic assays):
Giemsa stain (1:10 in WEISE's buffer12 pH 6.8)

NUMBER OF REPLICATIONS:
duplicates

METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED:
The tubes were centrifuged, the fixative removed and the cell pellet resuspended in a few drops of 60% acetic acid. Single drops of the cell suspension were spread on clean, grease-free glass slides on a hot plate (approx. 50°C) and the slides were left to air-dry. Two slides were prepared per culture, stained for 30 minutes in Giemsa stain (1:10 in WEISE's buffer12 pH 6.8), washed in buffer and left to air-dry. Permanent slides were made using CONSUL MOUNT mountant after clearing in xylene.


NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE (if in vitro cytogenicity study in mammalian cells):
For each culture (duplicate) 150 metaphases were examined, yielding a total of 300 metaphases for each concentration analysed.

DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
- Any supplementary information relevant to cytotoxicity:To examine the toxicity of the test item, 1000 cells were scored and the mitotic index was calculated as the percentage of cells in metaphase.
Rationale for test conditions:
Acceptance of the test was based on the following criteria:
o The concurrent negative control is considered acceptable for addition to the laboratory historical negative control database.
o Concurrent positive controls should induce responses that are compatible with those generated in the historical positive control data base and produce a statistically significant increase compared with the concurrent negative control.
o All three experimental conditions were tested unless one resulted in positive results (see paragraph 28 of the OECD 473).
o Adequate number of cells and concentrations are analysable (paragraphs 31 and 21 of the OECD 473).
o The criteria for the selection of top concentration are consistent with those described in paragraphs 22, 23 and 24 of the OECD 473.
o Both replicate cultures lead to similar results.
o Adequate numbers of cells (i.e. at least 1000 countable cells) and concentrations re-analyzable.
Evaluation criteria:
The test item is judged to have mutagenic properties with respect to chromosomal or chromatid change, if the following criteria are fulfilled:
o The number of chromosomal aberrations is significantly (at p  0.05) increased compared with the solvent control in at least one of the test concentrations
o The increase observed is concentration-dependent
o The increase should not occur in the severely cytotoxic range (mitotic index <0.25), as it is known that high cytotoxicity causes artefacts in the form of aberrations in in vitro chromosomal aberration tests
o Any of the results are outside the distribution of the historical negative control data
o A reproducible increase in the number of cells with chromosomal aberrations
o All three experimental conditions were tested unless one resulted in positive results
Statistics:
The assessment was carried out by a comparison of the number of chromosome aberrations of the samples with those of the solvent control, using the exact test of R. A. FISHER (p  0.05) as recommended by the UKEMS guidelines (1989).

Results and discussion

Test results
Key result
Species / strain:
lymphocytes:
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not determined
Vehicle controls validity:
not examined
Untreated negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no mutagenic potential (based on QSAR/QSPR prediction)

Applicant's summary and conclusion

Conclusions:
Under the present test conditions, Diisononyl 1 ,4-cyclohexanedicarboxylate (DINCD) tested up to a concentration of 2000 μg /ml medium in the absence and
presence of metabolic activation, revealed no indications of mutagenic properties with respect to chromosomal or chromatid damage.
In the same test, Mitomycin C and cyclophosphamide induced significant damages, which confirmed the validity of this assay .